SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
14 juil. 2023 07h55 HE
|
SciSparc Ltd
“We hope the outcome of this trial will enable the Company to procced with commercialization process for SCI-210 in Israel" TEL AVIV, Israel, July 14, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd....